Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AtriCure, Inc.ATRC · Entity 2704 | Director | May 20, 2021 | May 24, 2021 |
| Pulmonx CorpLUNG · Entity 2359 | Director | June 05, 2026 | June 09, 2026 |
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Exec. VP, CFO | May 08, 2019 | June 20, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AtriCure, Inc.
Report date May 20, 2021 · Filed May 24, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,103 |
Reported balance
After 2021-05-20 transaction · row 1
1 source rowRow 1 · 2021-05-20 · Grant · Acquired 1,749 · Balance 10,103 F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.
Pulmonx Corp
Report date June 05, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 133,910 |
Reported balance
After 2026-06-05 transaction · row 1
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 40,000 · Balance 133,910 F1: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 5, 2026, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 5, 2026, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made.
ZIMMER BIOMET HOLDINGS, INC.
Report date May 08, 2019 · Filed June 20, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,471 |
Reported balance
After 2019-05-08 transaction · row 1
1 source rowRow 1 · 2019-05-08 · Gift · Disposed 239 · Balance 25,471 F1: This transaction involved a gift of securities by the reporting person and is being voluntarily reported earlier than required. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction involved a gift of securities by the reporting person and is being voluntarily reported earlier than required.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2026 Filed Jun 9, 2026 21:59 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001402459-26-000002 · form4-06092026_090604.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,910 F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 5, 2026, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. Read SEC document |
| December 08, 2025 Filed Dec 9, 2025 22:59 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 23,321 | $1.99 | $46,408.79 |
DisclosureSEC source: 0001402459-25-000005 · form4-12092025_101256.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,910 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.97 to $2.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 00:39 UTC | Pulmonx Corp LUNG · Entity 2359 | PurchaseCommon Stock | 23,321 | $3.06 | $71,362.26 |
DisclosureSEC source: 0001415889-25-015859 · form4-06062025_120631.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,231 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.01 to $3.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 22:00 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 37,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015639 · form4-06042025_100633.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,910 F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 2, 2025, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. F2 · balance_after: The total includes 15,789 shares previously reported as indirectly owned through Kelly A Florin Trust. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 22:03 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 15,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015640 · form4-06052024_100604.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,968 F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 3, 2024, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 22:31 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 12,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033988 · doc4.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,752 F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 1, 2023, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:56 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034286 · doc4.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,132 F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 1, 2022, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 23:21 UTC | Pulmonx Corp LUNG · Entity 2359 | PurchaseCommon Stock | 2,500 | $40.00 | $100,000.00 |
DisclosureSEC source: 0001209191-21-046602 · doc4.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,532 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 21:33 UTC | Pulmonx Corp LUNG · Entity 2359 | PurchaseCommon Stock | 2,222 | $44.12 | $98,034.64 |
DisclosureSEC source: 0001209191-21-043518 · doc4.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,032 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $43.68 to $44.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:14 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040068 · doc4.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,810 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that will vest on the one-year anniversary of the date of grant of June 1, 2021. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:40 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 1,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035340 · doc4.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,103 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 20:17 UTC | Pulmonx Corp LUNG · Entity 2359 | PurchaseCommon Stock | 15,789 | $19.00 | $299,991.00 |
DisclosureSEC source: 0001628280-20-014288 · wf-form4_160192898820494.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 15,789 F1 · ownership.nature: The shares are directly held by Kelly A Florin Trust, for which the Reporting Person is a trustee. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:12 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001628280-20-014198 · wf-form4_160166954201553.xml · derivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-09-29 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal consecutive monthly installments commencing on September 30, 2020, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| May 20, 2020 Filed May 22, 2020 12:19 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031554 · doc4.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,354 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:20 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 5,902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-059294 · doc4.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,902 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 33% annually over three years from date of grant. Read SEC document |
| May 08, 2019 Filed Jun 20, 2019 20:51 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GiftCommon Stock | 239 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000137 · edgar.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,471 F1 · kind: This transaction involved a gift of securities by the reporting person and is being voluntarily reported earlier than required. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:13 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,551 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000078 · edgar.xml · derivative · entry 4 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,551 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: Earned RSUs vested on March 20, 2019. F4 · derivative.expiration_date: Earned RSUs vested on March 20, 2019. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:13 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 749 | $127.03 | $95,145.47 |
DisclosureSEC source: 0000911916-19-000078 · edgar.xml · nonDerivative · entry 3 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,710 F2 · shares: Represents shares withheld by the Company to satisfy tax withholing oblications on the vesting of restricted stock units ("RSU"). Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:13 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,551 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000078 · edgar.xml · nonDerivative · entry 2 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 22, 2019 20:13 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GiftCommon Stock | 490 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000078 · edgar.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,908 F1 · balance_after: Includes 72 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between June 30, 2018 and December 31, 2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:31 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 40,045 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0000911916-19-000063 · edgar.xml · derivative · entry 1 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,045 Underlying: Common Stock · 40,045 shares Expires 2029-02-26 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 21:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 2,551 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000045 · edgar.xml · derivative · entry 1 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,551 Underlying: Common Stock · 2,551 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 2,551 RSUs. F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2019. F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2019. F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 2,551 RSUs. F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 2,551 RSUs. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 16:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 4,213 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000149 · edgar.xml · derivative · entry 5 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,212 Underlying: Common Stock · 4,213 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F5 · derivative.exercise_date: 4,213 of the RSUs vested on August 1, 2018. The remaining 4,212 RSUs will vest on August 1, 2019. F5 · derivative.expiration_date: 4,213 of the RSUs vested on August 1, 2018. The remaining 4,212 RSUs will vest on August 1, 2019. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 16:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 1,840 | $125.58 | $231,067.20 |
DisclosureSEC source: 0000911916-18-000149 · edgar.xml · nonDerivative · entry 4 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,326 F3 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 16:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 4,213 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000149 · edgar.xml · nonDerivative · entry 3 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes 137 shares acquired under the ESPP on June 29, 2018. Read SEC document |
| June 12, 2018 Filed Aug 3, 2018 16:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GiftCommon Stock | 245 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000149 · edgar.xml · nonDerivative · entry 2 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,816 Read SEC document |
| May 16, 2018 Filed Aug 3, 2018 16:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GiftCommon Stock | 264 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000149 · edgar.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,061 F1 · balance_after: Includes 101 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan (the "ESPP") between December 29, 2017 and May 1, 2018. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:10 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 42,595 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000067 · edgar.xml · derivative · entry 1 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,595 Underlying: Common Stock · 42,595 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:36 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 45,085 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000042 · edgar.xml · derivative · entry 1 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,085 Underlying: Common Stock · 45,085 shares Expires 2028-02-20 Read SEC document |
| December 12, 2017 Filed Feb 14, 2018 14:38 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GiftCommon Stock | 245 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000027 · edgar.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,224 Read SEC document |
| November 06, 2017 Filed Nov 7, 2017 19:27 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GiftCommon Stock | 255 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000244 · edgar.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director · Interim CEO, Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,469 F1 · balance_after: Includes 120 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between June 30, 2017 and October 30, 2017. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 16:25 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 8,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000223 · edgar.xml · derivative · entry 1 Florin Daniel P · CIK 0001402459 · Director · Interim CEO, Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,425 Underlying: Common Stock · 8,425 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over two years in increments of 50% each year, commencing on August 1, 2018. F2 · derivative.expiration_date: Vests annually over two years in increments of 50% each year, commencing on August 1, 2018. Read SEC document |
| June 24, 2017 Filed Jun 27, 2017 17:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 16,225 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000197 · edgar.xml · derivative · entry 3 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,225 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: The RSUs vested on June 24, 2017. F4 · derivative.expiration_date: The RSUs vested on June 24, 2017. Read SEC document |
| June 24, 2017 Filed Jun 27, 2017 17:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 7,262 | $129.26 | $938,649.81 |
DisclosureSEC source: 0000911916-17-000197 · edgar.xml · nonDerivative · entry 2 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,604 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units. Read SEC document |
| June 24, 2017 Filed Jun 27, 2017 17:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 16,225 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000197 · edgar.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 226 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between June 30, 2016 and May 1, 2017. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 20:58 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 42,638 | $0.00 Strike: $121.88 | $0.00 |
DisclosureSEC source: 0000911916-17-000123 · edgar.xml · derivative · entry 1 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,638 Underlying: Common Stock · 42,638 shares Expires 2027-03-21 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 21, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.